vs
Penumbra Inc（PEN）与Rapid7, Inc.（RPD）财务数据对比。点击上方公司名可切换其他公司
Penumbra Inc的季度营收约是Rapid7, Inc.的1.8倍（$385.4M vs $217.4M），Penumbra Inc净利率更高（12.3% vs 1.4%，领先10.8%），Penumbra Inc同比增速更快（22.1% vs 0.5%），Penumbra Inc自由现金流更多（$68.0M vs $36.4M），过去两年Penumbra Inc的营收复合增速更高（17.6% vs 3.0%）
Penumbra Inc是2004年由Arani Bose与Adam Elsesser联合创立的美国医疗器械企业，总部位于加利福尼亚州阿拉米达，核心业务为研发、生产中风、动脉瘤等血管疾病介入治疗所用的专业医疗设备，产品已在全球多个国家的临床诊疗场景中投入使用。
Rapid7是全球领先的网络安全企业，提供漏洞管理、威胁检测与响应、云安全、安全分析等全系列安全解决方案，服务全球科技、医疗、金融、制造等行业的各类规模企业及公共部门客户，助力客户高效识别、应对和缓解网络安全风险。
PEN vs RPD — 直观对比
营收规模更大
PEN
是对方的1.8倍
$217.4M
营收增速更快
PEN
高出21.6%
0.5%
净利率更高
PEN
高出10.8%
1.4%
自由现金流更多
PEN
多$31.6M
$36.4M
两年增速更快
PEN
近两年复合增速
3.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $385.4M | $217.4M |
| 净利润 | $47.3M | $3.1M |
| 毛利率 | 68.0% | 68.9% |
| 营业利润率 | 15.4% | 1.0% |
| 净利率 | 12.3% | 1.4% |
| 营收同比 | 22.1% | 0.5% |
| 净利润同比 | 40.6% | 44.1% |
| 每股收益（稀释后） | $1.20 | $0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PENRPD
| Q4 25 | $385.4M | $217.4M | ||
| Q3 25 | $354.7M | $218.0M | ||
| Q2 25 | $339.5M | $214.2M | ||
| Q1 25 | $324.1M | $210.3M | ||
| Q4 24 | $315.5M | $216.3M | ||
| Q3 24 | $301.0M | $214.7M | ||
| Q2 24 | $299.4M | $208.0M | ||
| Q1 24 | $278.7M | $205.1M |
净利润PENRPD
| Q4 25 | $47.3M | $3.1M | ||
| Q3 25 | $45.9M | $9.8M | ||
| Q2 25 | $45.3M | $8.3M | ||
| Q1 25 | $39.2M | $2.1M | ||
| Q4 24 | $33.7M | $2.2M | ||
| Q3 24 | $29.5M | $15.4M | ||
| Q2 24 | $-60.2M | $6.5M | ||
| Q1 24 | $11.0M | $1.4M |
毛利率PENRPD
| Q4 25 | 68.0% | 68.9% | ||
| Q3 25 | 67.8% | 70.2% | ||
| Q2 25 | 66.0% | 70.6% | ||
| Q1 25 | 66.6% | 71.7% | ||
| Q4 24 | 66.8% | 69.5% | ||
| Q3 24 | 66.5% | 70.6% | ||
| Q2 24 | 54.4% | 70.7% | ||
| Q1 24 | 65.0% | 70.3% |
营业利润率PENRPD
| Q4 25 | 15.4% | 1.0% | ||
| Q3 25 | 13.8% | 2.7% | ||
| Q2 25 | 12.0% | 1.6% | ||
| Q1 25 | 12.4% | -0.0% | ||
| Q4 24 | 13.6% | 3.4% | ||
| Q3 24 | 11.7% | 6.0% | ||
| Q2 24 | -27.0% | 2.5% | ||
| Q1 24 | 4.3% | 4.7% |
净利率PENRPD
| Q4 25 | 12.3% | 1.4% | ||
| Q3 25 | 12.9% | 4.5% | ||
| Q2 25 | 13.3% | 3.9% | ||
| Q1 25 | 12.1% | 1.0% | ||
| Q4 24 | 10.7% | 1.0% | ||
| Q3 24 | 9.8% | 7.2% | ||
| Q2 24 | -20.1% | 3.1% | ||
| Q1 24 | 3.9% | 0.7% |
每股收益（稀释后）PENRPD
| Q4 25 | $1.20 | $0.05 | ||
| Q3 25 | $1.17 | $0.15 | ||
| Q2 25 | $1.15 | $0.13 | ||
| Q1 25 | $1.00 | $0.03 | ||
| Q4 24 | $0.88 | $0.08 | ||
| Q3 24 | $0.75 | $0.21 | ||
| Q2 24 | $-1.55 | $0.09 | ||
| Q1 24 | $0.28 | $0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $186.9M | $474.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.4B | $154.7M |
| 总资产 | $1.8B | $1.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资PENRPD
| Q4 25 | $186.9M | $474.7M | ||
| Q3 25 | $321.0M | $407.1M | ||
| Q2 25 | $421.8M | $511.7M | ||
| Q1 25 | $376.1M | $493.5M | ||
| Q4 24 | $324.4M | $521.7M | ||
| Q3 24 | $280.5M | $443.7M | ||
| Q2 24 | $288.3M | $442.6M | ||
| Q1 24 | $223.1M | $411.7M |
股东权益PENRPD
| Q4 25 | $1.4B | $154.7M | ||
| Q3 25 | $1.4B | $127.2M | ||
| Q2 25 | $1.3B | $90.4M | ||
| Q1 25 | $1.2B | $52.7M | ||
| Q4 24 | $1.2B | $17.7M | ||
| Q3 24 | $1.1B | $-5.1M | ||
| Q2 24 | $1.2B | $-52.6M | ||
| Q1 24 | $1.2B | $-86.4M |
总资产PENRPD
| Q4 25 | $1.8B | $1.7B | ||
| Q3 25 | $1.7B | $1.7B | ||
| Q2 25 | $1.7B | $1.6B | ||
| Q1 25 | $1.6B | $1.6B | ||
| Q4 24 | $1.5B | $1.7B | ||
| Q3 24 | $1.5B | $1.6B | ||
| Q2 24 | $1.5B | $1.5B | ||
| Q1 24 | $1.6B | $1.5B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $86.5M | $37.6M |
| 自由现金流经营现金流 - 资本支出 | $68.0M | $36.4M |
| 自由现金流率自由现金流/营收 | 17.7% | 16.8% |
| 资本支出强度资本支出/营收 | 4.8% | 0.5% |
| 现金转化率经营现金流/净利润 | 1.83× | 12.01× |
| 过去12个月自由现金流最近4个季度 | $174.9M | $146.2M |
8季度趋势，按日历期对齐
经营现金流PENRPD
| Q4 25 | $86.5M | $37.6M | ||
| Q3 25 | $58.3M | $39.0M | ||
| Q2 25 | $44.9M | $47.5M | ||
| Q1 25 | $49.0M | $29.8M | ||
| Q4 24 | $51.1M | $63.8M | ||
| Q3 24 | $56.5M | $44.0M | ||
| Q2 24 | $22.6M | $32.9M | ||
| Q1 24 | $38.3M | $31.1M |
自由现金流PENRPD
| Q4 25 | $68.0M | $36.4M | ||
| Q3 25 | $42.0M | $34.8M | ||
| Q2 25 | $29.4M | $46.6M | ||
| Q1 25 | $35.5M | $28.4M | ||
| Q4 24 | $45.7M | $62.6M | ||
| Q3 24 | $51.0M | $42.6M | ||
| Q2 24 | $18.1M | $32.6M | ||
| Q1 24 | $32.5M | $30.4M |
自由现金流率PENRPD
| Q4 25 | 17.7% | 16.8% | ||
| Q3 25 | 11.8% | 16.0% | ||
| Q2 25 | 8.7% | 21.8% | ||
| Q1 25 | 11.0% | 13.5% | ||
| Q4 24 | 14.5% | 28.9% | ||
| Q3 24 | 16.9% | 19.9% | ||
| Q2 24 | 6.0% | 15.7% | ||
| Q1 24 | 11.7% | 14.8% |
资本支出强度PENRPD
| Q4 25 | 4.8% | 0.5% | ||
| Q3 25 | 4.6% | 1.9% | ||
| Q2 25 | 4.6% | 0.4% | ||
| Q1 25 | 4.2% | 0.6% | ||
| Q4 24 | 1.7% | 0.5% | ||
| Q3 24 | 1.8% | 0.6% | ||
| Q2 24 | 1.5% | 0.1% | ||
| Q1 24 | 2.1% | 0.3% |
现金转化率PENRPD
| Q4 25 | 1.83× | 12.01× | ||
| Q3 25 | 1.27× | 3.97× | ||
| Q2 25 | 0.99× | 5.70× | ||
| Q1 25 | 1.25× | 14.14× | ||
| Q4 24 | 1.52× | 29.36× | ||
| Q3 24 | 1.91× | 2.85× | ||
| Q2 24 | — | 5.03× | ||
| Q1 24 | 3.48× | 22.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PEN
| Thrombectomy | $254.7M | 66% |
| Other | $130.7M | 34% |
RPD
| Products | $209.1M | 96% |
| Services | $8.2M | 4% |
